These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14664686)

  • 1. Therapists as fixed versus random effects-some statistical and conceptual issues: a comment on Siemer and Joormann (2003).
    Crits-Christoph P; Tu X; Gallop R
    Psychol Methods; 2003 Dec; 8(4):518-23. PubMed ID: 14664686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should providers of treatment be regarded as a random factor? If it ain't broke, don't "fix" it: a comment on Siemer and Joormann (2003).
    Serlin RC; Wampold BE; Levin JR
    Psychol Methods; 2003 Dec; 8(4):524-34. PubMed ID: 14664687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Power and measures of effect size in analysis of variance with fixed versus random nested factors.
    Siemer M; Joormann J
    Psychol Methods; 2003 Dec; 8(4):497-517. PubMed ID: 14664685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assumptions and consequences of treating providers in therapy studies as fixed versus random effects: reply to Crits-Christoph, Tu, and Gallop (2003) and Serlin, Wampold, and Levin (2003).
    Siemer M; Joormann J
    Psychol Methods; 2003 Dec; 8(4):535-44. PubMed ID: 14664688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A priori power analysis in longitudinal three-level multilevel models: an example with therapist effects.
    de Jong K; Moerbeek M; van der Leeden R
    Psychother Res; 2010 May; 20(3):273-84. PubMed ID: 19946814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapist variation within randomised trials of psychotherapy: implications for precision, internal and external validity.
    Walwyn R; Roberts C
    Stat Methods Med Res; 2010 Jun; 19(3):291-315. PubMed ID: 19608603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unpacking the therapist effect: Impact of treatment length differs for high- and low-performing therapists.
    Goldberg SB; Hoyt WT; Nissen-Lie HA; Nielsen SL; Wampold BE
    Psychother Res; 2018 Jul; 28(4):532-544. PubMed ID: 27616739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do therapist effects really impact estimates of within-patient mechanisms of change? A Monte Carlo simulation study.
    Falkenström F; Solomonov N; Rubel JA
    Psychother Res; 2020 Sep; 30(7):885-899. PubMed ID: 32482144
    [No Abstract]   [Full Text] [Related]  

  • 9. Psychiatric outcome studies (POS): does treatment help the patients? A Popperian approach to research in clinical psychiatry.
    Bech P; Lunde M; Bech-Andersen G; Lindberg L; Martiny K
    Nord J Psychiatry; 2007; 61 Suppl 46():4-34. PubMed ID: 17365777
    [No Abstract]   [Full Text] [Related]  

  • 10. The analysis of continuous outcomes in multi-centre trials with small centre sizes.
    Pickering RM; Weatherall M
    Stat Med; 2007 Dec; 26(30):5445-56. PubMed ID: 17924360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removing very low-performing therapists: A simulation of performance-based retention in psychotherapy.
    Imel ZE; Sheng E; Baldwin SA; Atkins DC
    Psychotherapy (Chic); 2015 Sep; 52(3):329-36. PubMed ID: 26301424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of omitting the interaction between crossed factors in cross-classified random effects modelling.
    Shi Y; Leite W; Algina J
    Br J Math Stat Psychol; 2010 Feb; 63(Pt 1):1-15. PubMed ID: 19243680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothesis tests for population heterogeneity in meta-analysis.
    Viechtbauer W
    Br J Math Stat Psychol; 2007 May; 60(Pt 1):29-60. PubMed ID: 17535578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of raw mean differences.
    Bond CF; Wiitala WL; Richard FD
    Psychol Methods; 2003 Dec; 8(4):406-18. PubMed ID: 14664679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of variance frameworks in clinical child and adolescent psychology: issues and recommendations.
    Jaccard J; Guilamo-Ramos V
    J Clin Child Adolesc Psychol; 2002 Mar; 31(1):130-46. PubMed ID: 11845645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating dose-response effects in psychological treatment trials: the role of instrumental variables.
    Maracy M; Dunn G
    Stat Methods Med Res; 2011 Jun; 20(3):191-215. PubMed ID: 19036909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating clinical significance: incorporating robust statistics with normative comparison tests.
    van Wieringen K; Cribbie RA
    Br J Math Stat Psychol; 2014 May; 67(2):213-30. PubMed ID: 23751017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A note on statistical power in multi-site randomized trials with multiple treatments at each site.
    Liu XS
    Br J Math Stat Psychol; 2014 May; 67(2):231-47. PubMed ID: 23710937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How many therapists? Practical guidance on investigating therapist effects in randomized controlled trials for eating disorders.
    Thompson D; Cachelin F; Striegel-Moore RH; Barton B; Shea M; Wilson GT
    Int J Eat Disord; 2012 Jul; 45(5):670-6. PubMed ID: 22407965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Assessment Design and Statistical Power for Detecting an Intervention Impact.
    Petras H
    Prev Sci; 2016 Oct; 17(7):819-29. PubMed ID: 27106693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.